Back to Annual Meeting
Back to Annual Meeting
|
Back to Annual Meeting
|
|
Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
4348.0: Tuesday, November 07, 2006: 8:30 PM-10:00 PM | |||
Oral | |||
| |||
| In this session we will explore different aspects of financing of pharmaceuticals, particularly with a focus on how we make cost-effective choices at the individual and community level. We start with exploring issues of contraceptive security and what progress has been made in recent years. We go on to look at the key financial considerations related to Antiretroviral Therapy, both through the choices we make and securing the supply chain. Finally we review the experience of revolving drug funds in different settings. | |||
| Learning Objectives: Refer to the individual abstracts for learning objectives | |||
| Maggie Huff-Rousselle, MA, MBA, PhD | |||
| Contraceptive Security Index 2003-2006: Monitoring progress towards achieving a secure global supply of contraceptives Dana G. Aronovich, Alan H. Bornbusch, PhD, William Winfrey, PhD, Ali Karim, PhD, Elizabeth Bunde | |||
| Key issues and considerations for implementation and expansion of national ARV drug supply chains Claudia Allers, Yasmin Chandani, Moses Muwonge, Steve Wilbur, Barbara Felling | |||
| Another HIV/AIDS threat: Cost effective choices Maggie Huff-Rousselle, MA, MBA, PhD, Annette De Mattos, MPH, Maureen Daura, MSc, Nicholas Chikwenya | |||
| 20 Years of Revolving Drug Funds: Should the public sector conduct business? Maggie Huff-Rousselle, MA, MBA, PhD, Abanish Rizal, MPH | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| Organized by: | International Health | ||
| Endorsed by: | HIV/AIDS; Maternal and Child Health | ||
| CE Credits: | CME, Health Education (CHES), Nursing | ||
The 134th Annual Meeting & Exposition (November 4-8, 2006) of APHA